Advanced Biomedical Technologies Inc. (ABMT) SEC Filing 10-Q Quarterly Report for the period ending Saturday, July 31, 2021

Advanced Biomedical Technologies Inc.

CIK: 1385799 Ticker: ABMT
Cover - shares
9 Months Ended
Jul. 31, 2021
Sep. 13, 2021
Cover [Abstract]  
Document Type10-Q 
Amendment Flagfalse 
Document Quarterly Reporttrue 
Document Transition Reportfalse 
Document Period End DateJul. 31, 2021 
Document Fiscal Period FocusQ3 
Document Fiscal Year Focus2021 
Current Fiscal Year End Date--10-31 
Entity File Number000-53051 
Entity Registrant NameAdvancedBioMedical Technologies, Inc. 
Entity Central Index Key0001385799 
Entity Incorporation, State or Country CodeNV 
Entity Address, Address Line One200Park Avenue 
Entity Address, Address Line TwoSuite 1700 
Entity Address, City or TownNewYork City 
Entity Address, State or ProvinceNY 
Entity Address, Postal Zip Code10166 
City Area Code(718) 
Local Phone Number766-7898 
Title of 12(b) SecurityClass A Common Stock 
Trading SymbolABMT 
Entity Current Reporting StatusYes 
Entity Interactive Data CurrentYes 
Entity Filer CategoryNon-accelerated Filer 
Entity Small Businesstrue 
Entity Emerging Growth Companyfalse 
Entity Shell Companyfalse 
Entity Common Stock, Shares Outstanding 70,224,850

View differences made from one quarter to another to evaluate Advanced Biomedical Technologies Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Advanced Biomedical Technologies Inc..


Assess how Advanced Biomedical Technologies Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Advanced Biomedical Technologies Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Advanced Biomedical Technologies Inc. provided additional information to their SEC Filing as exhibits

Ticker: ABMT
CIK: 1385799
Form Type: 10-Q Quarterly Report
Accession Number: 0001493152-21-022511
Submitted to the SEC: Mon Sep 13 2021 10:09:30 AM EST
Accepted by the SEC: Mon Sep 13 2021
Period: Saturday, July 31, 2021
Industry: Orthopedic Prosthetic And Surgical Appliances And Supplies

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: